Company News

August 20, 2024 | BALTIMORE –  Complete Omics is thrilled to announce an electrifying partnership with M20 Genomics, a trailblazer in single-cell and spatial transcriptomics! Together, these industry leaders are embarking on a groundbreaking collaboration set to redefine the landscape of single-cell multi-omics. By merging their cutting-edge technologies, this dynamic alliance is poised to revolutionize disease research and precision medicine, pushing the boundaries of what’s possible in healthcare innovation.

January 12, 2024 | BALTIMORE –  Complete Omics’ Clinical Proteomics team are thrilled to announce that Dr. Hui Zhang, a distinguished figure in the realm of proteomics, has joined the Complete Omics family as our Chief Scientific Officer (CSO) and Director for the Center for Advanced Proteomics. Dr. Zhang, a founding member of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), brings to our team a rich legacy of innovation and leadership in proteomics, especially known for her pioneering work in multi-omics studies on human cancers and her revolutionary innovation on the methods in studying N-Glycosylation on proteins.

November 25, 2023 | BALTIMORE –  Complete Omics management team are thrilled to announce a significant milestone for our company – a recent investment by Qiming Venture Partners. This partnership marks a pivotal moment in our journey, as we continue to advance our clinical proteomics platform and molecular diagnostics platform development. With this investment, we are poised to accelerate our efforts in bringing innovative solutions to the healthcare industry, ultimately aiming to improve patient outcomes through cutting-edge diagnostics.

June 1, 2023 | BALTIMORE –  Complete Omics’ Clinical Metablomics team are overjoyed to announce that Dr. Liang Zhao, an esteemed expert in metabolomics, proteomics, and lipidomics, with a profound focus on cancer metabolism and immuno-metabolism, has joined our MyMeta Force team as the leader. Dr. Zhao’s pioneering research involves the sophisticated application of mass spectrometry-based metabolomics and proteomics, alongside integrating molecular biology and bioinformatics, to unravel the biomedical significance of metabolites and proteins. His dedication to translating omics findings into clinical applications is notable, aiming at the development of innovative biomarkers, AI-enhanced diagnostic panels, and novel therapeutic strategies for cancer treatment.

July 18, 2021 | BALTIMORE –  Complete Omics team is thrilled to announce an extraordinary milestone for Complete Omics Inc. The Scientist’s Channel, renowned for spotlighting the trailblazers at the forefront of scientific inquiry and innovation, has featured our esteemed founder, Qing Wang, in a compelling showcase that highlights the groundbreaking work we are doing here at Complete Omics.